Why the study?
Does Ad.PRS-nNOS gene transfer reduce cardiac sympathetic neurotransmission in spontaneously hypertensive rats?
Population
Age-matched male spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats
Comparison
Ad.PRS-nNOS (adenovirus encoding neuronal NO… vs Ad.PRS-eGFP
Design
Preclinical
Follow-up
5 days
Authors
Loading...
Attenuates sympathetic drive in hypertensive rat atria; leaves open translation of nNOS gene transfer to human hypertension therapy.
Does Ad.PRS-nNOS gene transfer reduce cardiac sympathetic neurotransmission in spontaneously hypertensive rats?
Artificial upregulation of sympathetic nNOS via gene transfer with a noradrenergic promoter restores cGMP levels and attenuates norepinephrine release, offering a potential approach for correcting peripheral sympathetic hyperactivity in hypertension.
Li et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: